Alloy review
Every figure at this seller is a medication rate plus a $99 monthly care fee charged alongside it.
The verdict
Alloy charges $70 a month for compounded semaglutide, $100 for compounded tirzepatide and $115 for compounded liraglutide. A $99 monthly care fee sits on top of each, making the real figures $169, $199 and $214.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Liraglutide · Semaglutide · Tirzepatide
- Form
- Injection
- From
- $169/mo
- Prescription
- Required
Alloy sells three compounded GLP-1 molecules and the branded semaglutide, through an online weight-care service. The medication rates read $70, $100 and $115 a month on August 2, 2026, for semaglutide, tirzepatide and liraglutide. A separate care fee of $99 a month applies to each of them. Branded semaglutide starts at $199 for the medication, which is $298 once the fee is added.
Who writes the prescription, and what do they see?
The $99 line is named a care fee, which is the closest this seller comes to pricing clinician access. It is charged monthly and it is identical across all four medication rows. Whether it buys a scheduled visit, a message thread or a review of an intake form is not stated on the seller’s own pages. The medication rate and the care fee are billed as two lines, so the reader can at least see which is which.
The care fee is the structure here, and it is charged every month rather than once a year. It does not vary with the molecule, so the gap between semaglutide and tirzepatide stays $30 whichever figure is read. The branded row is the one where the medication rate itself moves, starting at $199 and running higher at larger doses. Branded tirzepatide is $299 for the medication, or $398 with the fee.
What happens when the dose goes up?
The compounded rows carry one medication rate each, with no per-dose ladder published beside them. The branded semaglutide row is the exception: it starts at $199 and runs higher at larger doses. A reader on that route should expect the medication line to move while the care fee stays at $99. Liraglutide is dosed daily rather than weekly, so its escalation runs on a different schedule from the other two.
What the price includes
A reader comparing sellers on the medication rate alone would put Alloy near the bottom of this market. Adding the fee moves it to $169, which is a different position entirely. The fee is the same whether one molecule is taken or another, so it weighs heaviest where the medication rate is smallest. On semaglutide it is more than half the total.
What it claims, and what it cites
Three of the four rows are compounded preparations, made by a pharmacy rather than a manufacturer, and not FDA-approved. The branded semaglutide row is the manufacturer's finished product. Liraglutide is the older molecule of the three and is dosed daily rather than weekly. The trial evidence for each was generated with the approved products at label doses, and compounded preparations were not studied.
Where it holds up, and where it does not
- Strength: Three compounded molecules at one seller
- Strength: Care fee amount published, not implied
- Strength: Branded and compounded routes both listed
- Limitation: Care fee is $99 every month
- Limitation: Medication rate excludes that fee
- Limitation: Fee dominates a low medication rate
What the evidence says about this kind of treatment
The assessment above is about Alloy. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader comparing three molecules at a single seller, where the same fixed fee sits on top of each of them.
- Wrong for
- A reader who wants one charge a month, since the medication and the care fee are billed as two separate lines here.
How Alloy compares
| Seller | Who it suits | Go |
|---|---|---|
| Collective | A reader who will stay on treatment for a full twelve months, which is the term the annual membership is priced against. | See Collective → |
 Maximus | A reader weighing a compounded preparation against the manufacturer's own pen, where the semaglutide decision costs nothing either way. | See Maximus → |
| Lean Meds | A reader deciding between paying month to month and committing a year up front, because both rungs are published side by side. | See Lean Meds → |
More GLP-1 telehealth sellers reviews: Apex MDAVARA RxBayan HealthBioGlow HealthDoctorAdamEmbody
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Can the $99 care fee be declined?
- It is charged alongside every medication row on this seller's page, so the figures this site ranks on include it. A reader should treat $169 rather than $70 as the monthly cost of compounded semaglutide here.
- Which molecule is cheapest once the fee is counted?
- Compounded semaglutide, at $169 a month. Compounded tirzepatide is $199 and compounded liraglutide $214, because the fee is identical across all three.
- How does the branded route compare?
- Branded semaglutide starts at $199 for the medication, or $298 with the care fee, against $169 for the compounded preparation. Branded tirzepatide is $398 on the same basis.
- Is Alloy expensive compared with other GLP-1 telehealth sellers?
- Alloy publishes a starting figure of $169/mo. Across the 32 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $139, which puts Alloy above the median. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.